Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Noguer, Emmanuel"'
Autor:
Voisin, Maud, de Medina, Philippe, Mallinger, Arnaud, Dalenc, Florence, Huc-Claustre, Emilie, Leignadier, Julie, Serhan, Nizar, Soules, Régis, Ségala, Grégory, Mougel, Aurélie, Noguer, Emmanuel, Mhamdi, Loubna, Bacquié, Elodie, Iuliano, Luigi, Zerbinati, Chiara, Lacroix-Triki, Magali, Chaltiel, Léonor, Filleron, Thomas, Cavaillès, Vincent, Saati, Talal Al, Rochaix, Philippe, Duprez-Paumier, Raphaelle, Franchet, Camille, Ligat, Laetitia, Lopez, Fréderic, Record, Michel, Poirot, Marc, Silvente-Poirot, Sandrine
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2017 Oct . 114(44), E9346-E9355.
Externí odkaz:
https://www.jstor.org/stable/26488889
Autor:
Segala, Gregory, David, Marion, de Medina, Philippe, Poirot, Mathias C., Serhan, Nizar, Vergez, François, Mougel, Aurelie, Saland, Estelle, Carayon, Kevin, Leignadier, Julie, Caron, Nicolas, Voisin, Maud, Cherier, Julia, Ligat, Laetitia, Lopez, Frederic, Noguer, Emmanuel, Rives, Arnaud, Payré, Bruno, Saati, Talal al, Lamaziere, Antonin, Despres, Gaëtan, Lobaccaro, Jean-Marc, Baron, Silvere, Demur, Cecile, de Toni, Fabienne, Larrue, Clément, Boutzen, Helena, Thomas, Fabienne, Sarry, Jean-Emmanuel, Tosolini, Marie, Picard, Didier, Record, Michel, Récher, Christian, Poirot, Marc, Silvente-Poirot, Sandrine
Publikováno v:
Nature Communications, Vol. 8, No 1 (2017) P. 1903
Nature Communications
Nature Communications, Nature Publishing Group, 2017, 8 (1), pp.1903. ⟨10.1038/s41467-017-01948-9⟩
Nature Communications, Vol 8, Iss 1, Pp 1-17 (2017)
Nature Communications, 2017, 8 (1), pp.1903. ⟨10.1038/s41467-017-01948-9⟩
Nature Communications
Nature Communications, Nature Publishing Group, 2017, 8 (1), pp.1903. ⟨10.1038/s41467-017-01948-9⟩
Nature Communications, Vol 8, Iss 1, Pp 1-17 (2017)
Nature Communications, 2017, 8 (1), pp.1903. ⟨10.1038/s41467-017-01948-9⟩
Dendrogenin A (DDA) is a newly discovered cholesterol metabolite with tumor suppressor properties. Here, we explored its efficacy and mechanism of cell death in melanoma and acute myeloid leukemia (AML). We found that DDA induced lethal autophagy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ba1092a91121f255a35e4f3bc8a01905
https://archive-ouverte.unige.ch/unige:100456
https://archive-ouverte.unige.ch/unige:100456
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Recher, Christian, David, Marion *, de Medina, Philippe *, Bize, Cécile *, Serhan, Nizar *, Paillasse, Michael R *, Saland, Estelle *, Noguer, Emmanuel *, Cherier, Julia *, Demur, Cécile *, Larrue, Clément *, de Toni, Fabienne *, Vergez, François *, Sarry, Jean-emmanuel *, Silvente-Poirot, Sandrine *, Poirot, Marc *
Publikováno v:
In Blood 6 December 2014 124(21):3767-3767
Autor:
Segala G; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France.; Département de Biologie Cellulaire, Université de Genève, Genève, 1211, Switzerland., David M; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France.; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., de Medina P; AFFICHEM, Toulouse, F-31400, France., Poirot MC; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Serhan N; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Vergez F; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, F-31100, France., Mougel A; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Saland E; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Carayon K; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Leignadier J; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Caron N; AFFICHEM, Toulouse, F-31400, France., Voisin M; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Cherier J; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Ligat L; UMR 1037-CRCT, Pole Technologique, Toulouse, F-31037, France., Lopez F; UMR 1037-CRCT, Pole Technologique, Toulouse, F-31037, France., Noguer E; AFFICHEM, Toulouse, F-31400, France., Rives A; AFFICHEM, Toulouse, F-31400, France., Payré B; Centre de Microscopie Electronique Appliquée à la Biologie, Toulouse, F-31062, France., Saati TA; INSERM-US006 ANEXPLO/CREFRE F-31024, Toulouse, F-31024, France., Lamaziere A; Laboratory of Mass Spectrometry, INSERM ERL 1157, CNRS UMR 7203 LBM, Sorbonne Universités-UPMC, CHU Saint-Antoine, Paris, F-75012, France., Despres G; Laboratory of Mass Spectrometry, INSERM ERL 1157, CNRS UMR 7203 LBM, Sorbonne Universités-UPMC, CHU Saint-Antoine, Paris, F-75012, France., Lobaccaro JM; Université de Clermont Auvergne, CNRS, INSERM, GReD, Clermont-Ferrand, F-63001, France., Baron S; Université de Clermont Auvergne, CNRS, INSERM, GReD, Clermont-Ferrand, F-63001, France., Demur C; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, F-31100, France., de Toni F; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Larrue C; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Boutzen H; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Thomas F; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Dose Individualisation of Anticancer Drugs Team, Toulouse, F-31037, France., Sarry JE; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France., Tosolini M; UMR 1037-CRCT, Pole Technologique, Toulouse, F-31037, France., Picard D; Département de Biologie Cellulaire, Université de Genève, Genève, 1211, Switzerland., Record M; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France., Récher C; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Chemoresistance, Stem Cells and Metabolism in Acute Myeloid Leukemia, Toulouse, F-31037, France. recher.christian@iuct-oncopole.fr.; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, Toulouse, F-31100, France. recher.christian@iuct-oncopole.fr., Poirot M; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France. marc.poirot@inserm.fr., Silvente-Poirot S; UMR 1037-CRCT, Université de Toulouse, INSERM, UPS, Cholesterol Metabolism and Therapeutic Innovations Team, Toulouse, F-31037, France. sandrine.poirot@inserm.fr.
Publikováno v:
Nature communications [Nat Commun] 2017 Dec 04; Vol. 8 (1), pp. 1903. Date of Electronic Publication: 2017 Dec 04.